Abstract:Objective To evaluate the efficacy and safety of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer (LARC) before surgery.Methods A total of 291 LARC patients who received preoperative chemoradiotherapy and surgery with or without postoperative adjuvant chemotherapy from March 2003 to May 2012 were included in the study.The radiotherapy delivered was two-dimensional conformal radiotherapy (2DRT) and three-dimensional conformal radiotherapy (3DRT),and the total dose ranged from 45 to 50 Gy in 23-25 fractions.All the patients received preoperative chemotherapy including FOLFOX6,XELOX,and Xeloda for 2-4 cycles.Surgery following the principle of total mesorectal excision was performed 3-8 weeks after radiotherapy.Postoperative adjuvant chemotherapy was delivered to 134 patients.The overall survival (OS),disease-free survival (DFS),relapse-free survival (RFS),and distant metastasis-free survival (DMFS) were determined using the Kaplan-Meier method,and survival difference analysis and univariate prognostic analysis were performed using the log-rank test.Multivariate prognostic analysis was performed using the Cox proportional hazard model.Results All the patients completed the preoperative neoadjuvant chemoradiotherapy and surgery.The rate of radical resection (R0) was 98.9％,and the sphincter preservation rate was 53.6％.The downstaging rates in tumor (T)stage,node (N) stage,and clinical stage were 73.1％,83.6％,and 79.4％,respectively.Pathologic complete response rate was 26.8％.Grade 3 adverse hematologic reactions,grade 3 diarrhea,and grade 3 radiodermatitis were observed in 7.9％,7.2％ and 2.7％ of total patients,respectively.Postoperative perineal pain and delayed wound healing were reported in 12.3％ and 8.2％ of total patients,respectively.The follow-up rate was 94.5％ and the 5-year sample size was 95 patients.The 5-year OS,DFS,RFS,and DMFS were 76.6％,72.1％,88.8％,and 79.7％,respectively.The 5-year local recurrence rate and distant metastasis rate were 7.5％ and 15.8％,respectively.Multivariate analysis revealed that the postoperative pathological staging was a prognostic influencing factor.Conclusions Preoperative neoadjuvant chemoradiotherapy increases the R0 and sphincter preservation rates,and results in significant tumor downstaging.Treatment-related adverse reactions are moderate and perioperative complications are not increased.The local recurrence rate is low and long-term survival rate is increased.Clinical application of preoperative neoadjuvant chemoradiotherapy as a standard treatment regimen for LARC is highly recommended.

Efficacy of Preoperative Concurrent Chemoradiotherapy in Treatment of Locally Advanced Rectal Cancer

Pre-operative radiochemotherapy of locally advanced rectal cancer.

Efficacy of the radiotherapy combined with oxaliplatin and capecitabine in the treatment of local advanced rectal cancer

Efficacy of Preoperative Concurrent Chemoradiotherapy in Treatment of Locally Advanced Middle-Low Rectal Cancer

[Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer]

Efficacy and Safety of Preoperative Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer : a Clinical Analysis of 291 Patients

[Preoperative chemoradiotherapy as neoadjuvant therapy for 35 patients with locally advanced lower rectal carcinoma].

Preliminary clinical observation of neoadjuvant chemoradiotherapy for low and locally advanced rectal cancer

Long-term efficacy of preoperative chemoradiotherapy combined with total mesorectal excision for locally advanced rectal cancer: an analysis of 241 patients

[Evaluation of Preoperative Radiotherapy or Chemoradiotherapy in Sphincter Preservation for Locally Advanced Middle-Low Rectal Cancer].

Management of Locally Advanced Rectal Cancer with Preoperative Three-Dimensional Conformal Radiotherapy Combined with Chemotherapy

Efficacy and safety of neoadjuvant chemoradiotherapy versus neoadjuvant radiotherapy for stages II-III rectal cancer: a Meta-analysis

Efficacy of Preoperative Neoadjuvant Simultaneous Integrated Boost Intensity?modulated Radiotherapy Combined with Preoperative Chemotherapy for Locally Advanced Rectal Cancer:A Phase Ⅱ Clinical Study

[Preoperative Chemoradiotherapy with FOLFOX in Low Rectal Cancer: a Multicenter Study].

[Tumor Downstaging Through Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer].

Comparison of Two Different Neoadjuvant Chemoradiatiotherapy Regimens for Locally Advanced Rectal Cancer: Results of a Phase II, Multicenter, Randomized Trial.

Effect of chemoradiotherapy for locally advanced unresectable rectal cancer

Clinical efficacy of preoperative SIB-IMRT for 26 cases of locally-advanced low rectal cancer

Efficacy of Preoperative Neoadjuvant Simultaneous Integrated Boost IMRT Radiation Therapy Combined with Preoperative Chemotherapy for Locally Advanced Rectal Cancer: A Prospective II Clinical Study

Role of sphincter preserving surgery with neoadjuant chemoradiotherapy for locally advanced low rectal cancer

Preoperative Radiotherapy Combined with Simultaneous Chemotherapy with Capecitabine Plus Oxaliplatin Versus Surgery Alone: A Single-Centered, Phase Ii Study in Patients with Mid/Low Rectal Cancer.